Menu

Rebecca Ross

Special Counsel

rross@cooley.com

Rebecca Ross concentrates her practice in international trade, national security and anti-corruption compliance and enforcement matters. She counsels foreign and domestic companies, investors and underwriters regarding the sanctions regulations administered by the US Department of the Treasury’s Office of Foreign Assets Control (OFAC), the Export Administration Regulations (EAR) administered by the US Department of Commerce’s Bureau of Industry and Security (BIS), the International Traffic in Arms Regulations (ITAR) administered by the US Department of State’s Directorate of Defense Trade Controls (DDTC), the US Foreign Corrupt Practices Act (FCPA) and other anti-corruption laws, and national security reviews conducted by the Committee on Foreign Investment in the United States (CFIUS).

Download full bio 

Experience

  • Structure Therapeutics – $185.3 Million IPO 

  • Apollo Endosurgery to Be Acquired by Boston Scientific 

  • Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion 

  • Tempus Labs – $175 Million in Funding 

  • Fernweh to Acquire Controlling Interest in AZZ Infrastructure Solutions Segment 

  • View all

Education

  • George Washington University Law School
    JD, 2006

  • Davidson College
    BA, cum laude, Phi Beta Kappa, 2000


Admissions & Credentials

District of Columbia

New York

Rankings & Accolades

    Chambers USA: Nationwide – International Trade: Export Controls & Economic Sanctions